Skip to content

The clinical trial of intervention hypertension diastolic dysfunction based on blood syndrome pathogenesis .

The clinical trial of intervention hypertension diastolic dysfunction based on blood syndrome pathogenesis .

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-14004672
Enrollment
Unknown
Registered
2014-09-21
Start date
2014-05-19
Completion date
Unknown
Last updated
2017-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension Combined diastolic dysfunction

Interventions

control group:Western medicine foundation treatment and Medcine
test group 1:Western medicine foundation treatment and bu-shen-
test group 2:Western medicine foundation treatment and bu-shen-

Sponsors

Dongfang Hospital Affiliated to Beijing University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. In accordance with the diagnosis Hypertension, patients have been carried out Lifestyle interventions, or lifestyle intervention + specification antihypertensive drug therapy,and blood pressure control compliance for nearly a month; 2. In accordance with the diagnosis diastolic dysfunction; 3. TCM syndrome differentiation: liver and kidney deficiency, qi deficiency and blood stasis; 4. Aged between 18 and 80 years old,regardless of sex; 5. Voluntary and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with secondary hypertension or malignant hypertension; 2. Patients with acute cardiovascular and cerebrovascular events occurred within recent six months; 3. Patients combined cardiomyopathy, pericardial disease, valvular heart disease, severe arrhythmias; 4. Patients combined diabetes in poor glycemic control(GLU>7mmol/L), hyperthyroidism, pernicious tumor, mental illness and serious diseases of liver, kidney, hematopoietic system; 5. Pregnancy or breast-feeding women; 6. Patients participated in other drug clinical trials in nearly a month.

Design outcomes

Primary

MeasureTime frame
blood routine;urine routine;ALT;AST;ALP;GGT;TBIL;BUN;Cr;

Secondary

MeasureTime frame
E/A;Ea/Aa;E/Ea;IVRT;DT;traditional chinese medicine syndromes integration;BNP;

Countries

China

Contacts

Public ContactQian Lin

Dongfang Hospital Affiliated to Beijing University of Traditional Chinese Medicine

13910565673@126.com+86 010-67689611

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026